We're thrilled to share the latest results from the HOPE-2 clinical trial, showing promising long-term efficacy of #Deramiocel in treating #Duchenne muscular dystrophy cardiomyopathy.
Read the press release: https://ow.ly/bMEa50VpPK7 https://x.com/NSPharmaInc/status/1905286589363691924/photo/1
The NSP team had an incredible time at the #MDAConference, connecting with experts, advocates, and families who share our commitment to the neuromuscular community.
Thank you to everyone who stopped by to chat with us! Until next time!